Data Sheet 1_Case Report: Lenalidomide as a novel maintenance therapy for metastatic folli

A single clinical case report details the use of lenalidomide as maintenance therapy for metastatic follicular dendritic cell sarcoma. The report describes a patient achieving sustained remission for approximately seven years following chemotherapy. The PDF document was authored by Saarang Kashyap and last updated in May 2026.

Use Cases

• Reviewing clinical evidence for lenalidomide in follicular dendritic cell sarcoma based on the documented case.
• Studying long-term outcomes of maintenance therapies for rare cancers based on the seven-year remission period.
• Comparing treatment efficacy against conventional chemotherapy regimens mentioned in the description.

Strengths

• Documented a sustained clinical response of approximately seven years.
• Focuses on a rare malignancy with limited therapeutic options.

Limitations

• Contains data from a single patient case, limiting statistical power.
• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.

Provenance

Source

Saarang Kashyap

Collection Method

Clinical case report.

Freshness

Last updated 2026-05-14 04:29:34; freshness should be verified.